William D. Waddill

Director

William D. Waddill (Director) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Protagonist Therapeutics, Inc. (PTGX). The largest single filing was $1.7M of PTGX (20,000 sh × $83.68, as filed), executed Feb 6.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$6.1M

shares × price, as filed

Last traded

Jun 23

Filed Jun 25

Median ADV $107.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $6.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names

PTGX

Protagonist Therapeutics, Inc. PTGX · 0 buys · 8 sells 8 filings ARWR

Arrowhead Pharmaceuticals, Inc. ARWR · 0 buys · 1 sell 1 filing

Recent filings

PTGXSALE Protagonist Therapeutics, Inc. View filing → $217K
4,000 sh × $54.25
Exec Mar 17 2025
Filed Mar 19 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. View filing → $360K
8,000 sh × $45.00
Exec Sep 10 2024
Filed Sep 12 2024 · 5:30 PM ET